Table 3.
Correlations between β-CIT, PCBs and classical confounders and other potential confounders in the β-CIT study cohort.
Cofounder | β-CIT | Serum PCBs | |||
---|---|---|---|---|---|
Na | Correlation | p | Correlation | p | |
Serum PCBs | 89 | -0.322 | 0.002 | ||
β-CIT | 89 | -0.322 | 0.002 | ||
Sex | 89 | 0.242 | 0.022 | 0.029 | 0.785 |
Age | 89 | -0.338 | 0.001 | 0.273 | 0.010 |
Body Mass Index | 85 | -0.192 | 0.078 | 0.148 | 0.177 |
Serum DDE | 89 | -0.315 | 0.003 | 0.305 | 0.004 |
Serum DDT | 89 | -0.201 | 0.059 | 0.681 | 0.001 |
Serum Lipids | 89 | 0.261 | 0.013 | -0.218 | 0.040 |
Use of Cardio Medications | 84 | -0.214 | 0.050 | 0.001 | 0.992 |
Education | 85 | -0.063 | 0.566 | -0.110 | 0.314 |
Bone Lead | 86 | -0.006 | 0.960 | -0.083 | 0.448 |
Income | 83 | -0.093 | 0.401 | -0.012 | 0.916 |
Caffeinated Drinks (past year) | 78 | 0.084 | 0.467 | 0.016 | 0.892 |
Alcoholic Drinks (past year) | 85 | -0.053 | 0.629 | 0.051 | 0.643 |
Alcoholic Drinks (past 10 years) | 85 | -0.086 | 0.431 | 0.038 | 0.727 |
Cigarette Packs (past year) | 85 | 0.009 | 0.934 | 0.090 | 0.412 |
Cigarette Packs (past 10 years) | 85 | 0.054 | 0.621 | 0.027 | 0.806 |
Use of CNS Active Medications | 78 | 0.099 | 0.388 | 0.053 | 0.646 |
Use of NSAIDS | 78 | -0.032 | 0.784 | -0.037 | 0.750 |
TSH | 54 | -0.121 | 0.384 | 0.263 | 0.055 |
T4 | 54 | 0.049 | 0.727 | 0.056 | 0.689 |
FT4 | 54 | -0.041 | 0.771 | 0.058 | 0.677 |
T3 | 54 | -0.090 | 0.519 | 0.073 | 0.598 |
FT3 | 54 | -0.212 | 0.124 | 0.146 | 0.292 |
Number of observations varies across variables due to missing values